NIAID Funding News, December 4, 2024

December 4, 2024 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-12-04 Feature Articles  Don't Waste Your Time: Take an Extra Minute When Selecting NOFOs, Form Sets We've now reached a stretch of time in which two form sets (i.e., FORMS-H and FORMS-I) and two versions of certain notices of funding opportunities (NOFOs) will be active simultaneously. Opportunities and Resources Collaborate to Defeat Antibiotic-Resistant Bacterial Infections NIAID will support multidisciplinary, collaborative research programs focused on discovery to early development research to inform new approaches to prevent, diagnose, and treat antibiotic-resistant bacterial infections. Establishing Preclinical Animal Models to Study Post-TB Lung Disease Development While most of our understanding of Post-TB Lung Disease (PTLD) comes from long-term human cohorts, using animal models for PTLD development could help address difficult mechanistic questions when relying solely on human studies. Explore Mechanisms of Adverse Health Effects on the Nervous System After Toxic Chemical Exposure Propose research on the fundamental mechanisms of toxicity of highly toxic Chemicals of Concern but also on potential new targets to inform the development of medical countermeasures that would be effective during and after civilian mass exposure situations.  In The News Webinar Describes Changes Coming to Fellowship Application and Review The newly structured candidate section will ask for four personal statements: 1) a statement of professional and fellowship goals, 2) a statement of fellowship qualifications, 3) a self-assessment, and 4) a statement of scientific perspective. Create an ORCID Account in Preparation for the May 2025 Common Forms for Biosketch Transition Investigators will soon be required to use Science Experts Network Curriculum Vitae (SciENcv) to complete Common Forms and the NIH Biographical Sketch Supplement to produce digitally certified PDFs for their application submission. News Briefs and Worth Repeating HHS Policy Also Caps Indirect Salaries Paid Using Award Funds Small Business Recipients—Get Help to Hone Your Product Pitch Read Summary of Recent Artificial Intelligence Use Cases at NIH Advice Corner How to Determine Where Your Application Will Be Reviewed If you know your application will go to a Center for Scientific Review study section, you can request assignment to the most appropriate one. Reader Questions "Can my program officer help to resolve a dispute with my grant's subrecipient?" "One of my key personnel listed several preprints in their biosketch. Is that acceptable?" New Funding Opportunities NOT-AI-24-085, Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes PAR-25-251, NIAID Career Transition Award (K22, Independent Clinical Trial Not Allowed) PAR-25-300, Targeting Cell Surface HIV Envelope for Cell Elimination (R01, Clinical Trial Not Allowed) PAR-25-134, Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15, Clinical Trial Not Allowed) PAR-25-214, Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21, Clinical Trial Not Allowed) HHS-NIH-NIAID-BAA2025-1, 2026 NIAID DMID Omnibus Broad Agency Announcement RFA-AI-24-076, Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-Infections (AT LASt) (R61/R33, Clinical Trial Not Allowed) NOT-AI-24-081, Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine RFA-DA-26-034, Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01, Clinical Trial Not Allowed) NOT-AI-24-072, Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery NOT-AI-24-078, Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity Find other announcements at NIAID Opportunities and Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107